CITIGROUP INC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$451,729
+43.6%
10,951
+94.4%
0.00%
Q2 2023$314,602
+11.0%
5,634
+10.9%
0.00%
Q1 2023$283,525
-81.7%
5,082
-88.0%
0.00%
-100.0%
Q4 2022$1,545,748
+104.7%
42,419
+59.9%
0.00%
+100.0%
Q3 2022$755,000
-89.7%
26,532
-83.7%
0.00%
-80.0%
Q2 2022$7,359,000
-25.1%
162,652
+26.0%
0.01%
-16.7%
Q1 2022$9,823,000
-29.2%
129,117
+38.6%
0.01%
-14.3%
Q4 2021$13,873,000
+33.1%
93,129
+30.1%
0.01%
+16.7%
Q3 2021$10,423,000
-42.3%
71,596
-22.4%
0.01%
-45.5%
Q2 2021$18,067,000
+35.1%
92,261
+24.9%
0.01%
+22.2%
Q1 2021$13,374,000
+33.3%
73,889
+4.2%
0.01%
+50.0%
Q4 2020$10,036,000
+63.8%
70,878
+44.2%
0.01%
+50.0%
Q3 2020$6,128,000
+1762.6%
49,153
+1235.7%
0.00%
Q2 2020$329,000
+585.4%
3,680
+379.2%
0.00%
Q1 2020$48,000
+26.3%
768
+53.6%
0.00%
Q4 2019$38,0005000.00%
Other shareholders
10X GENOMICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Venrock Management VI, LLC 962,309$174,178,00096.89%
Foresite Capital Management II, LLC 2,253,528$407,889,00093.76%
Foresite Capital Management I, LLC 1,000,000$181,000,00091.29%
12 West Capital Management LP 1,922,000$347,882,00016.58%
FINANCIAL CONSULATE, INC 158,758$28,735,00011.65%
Meritech Capital Associates V L.L.C. 2,123,356$384,327,0009.48%
Andar Capital Management HK Ltd 48,000$8,688,0009.16%
JS Capital Management LLC 517,256$93,623,0004.84%
Ground Swell Capital, LLC 3,713$672,0002.17%
Renaissance Capital LLC 79,518$14,393,0002.13%
View complete list of 10X GENOMICS INC shareholders